GenMark Investor Wants Records On $1.8B Roche Deal
A GenMark Diagnostics shareholder sued the biotech company Wednesday in Delaware Chancery Court in a bid to gain access to records regarding Roche's planned $1.8 billion acquisition of the disease-testing business,...To view the full article, register now.
Already a subscriber? Click here to view full article